MedPath

To evaluate the efficacy of Kapiva Diafree juice for the Type 2 Diabetic Patients and Improving Quality of Life

Phase 4
Completed
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2022/04/041781
Lead Sponsor
Kapiva Adret Retail Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

1.Subjects aged > 18 years of age who agree to participate in the study willing and able to answer the questionnaire and give their written informed consent.

2. Participant with initial HBA1c value 6.5% and above

3. Subjects with a physician certified report on their sugar profile of 3 months

prior to enrolment for trial.

4. Patients with a diagnosis of T2DM for >1 year prior to signing up for clinical

trials.

5. Patients who are under the treatment of oral antidiabetic drugs

6. Patients who have not changed their medication in the last three months prior

to signing up for the study. (However, dosage modifications are allowed)

7. Subjects with Body Mass Index (BMI) >27 kg/m2 and <45 kg/m2

8. Women of childbearing potential must be willing to use double-barrier contraception for the entire study

Exclusion Criteria

1.Pregnant and lactating women

2. Patients who are on insulin therapy.

3. Patients with a history of chronic illness type 1 diabetes and /or history of

ketoacidosis

4. Patients with Insulin use and/or hyperosmolar hyperglycaemic state

5. Patients with secondary diabetes (including disease of the exocrine pancreas,

endocrinopathies)

6. Any condition of the patient which may have an impact on the objective and

outcome of the trial example: patients currently undergoing major/ minor surgical procedures

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath